LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto 4050-313, Portugal.
QOPNA & LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro 3810-193, Portugal.
J Nat Prod. 2020 Oct 23;83(10):3131-3140. doi: 10.1021/acs.jnatprod.0c00728. Epub 2020 Oct 2.
Several epidemiological studies indicate that neutrophils, under hyperglycemic conditions, are involved in the perpetuation of the inflammatory status, a characteristic of diabetes mellitus, leading to the production of prodigious quantities of reactive species and the release of neutrophil extracellular traps (NETs). Accordingly, our aim was to study the ability of a panel of 25 structurally related chalcones to modulate human neutrophil oxidative burst and the production of NETs under physiological and high glucose conditions. In general, all chalcones presented similar effects under physiological and high glucose conditions. 2',4-Dihydroxy-3-methoxychalcone (), here studied for the first time, was the most active (IC ≤ 5 μM) on the inhibition of neutrophil oxidative burst, showing the importance of the presence of hydroxy substituents at the C-2' and C-4 positions of the A and B rings, respectively, and a 3-methoxy substituent at B ring of the chalcone scaffold. In the present experimental conditions, NETs release only occurred under high glucose levels. The pentahydroxylated chalcone was the only one that was able to modulate the NETs release. This study provided important considerations about the chalcones' scaffold and their modulatory effect on human neutrophil activities at physiological and high glucose conditions, evidencing their potential use as complementary antidiabetic agents.
几项流行病学研究表明,在高血糖条件下,中性粒细胞参与了炎症状态的持续存在,这是糖尿病的特征,导致产生大量的活性物质和中性粒细胞细胞外陷阱(NETs)的释放。因此,我们的目的是研究一组 25 种结构相关的查尔酮在生理和高葡萄糖条件下调节人中性粒细胞氧化爆发和 NETs 产生的能力。一般来说,所有查尔酮在生理和高葡萄糖条件下都表现出相似的作用。2',4-二羟基-3-甲氧基查尔酮(),在此首次研究,对抑制中性粒细胞氧化爆发最有效(IC ≤ 5 μM),表明 A 和 B 环的 C-2'和 C-4 位分别存在羟基取代基和查尔酮骨架 B 环上的 3-甲氧基取代基的重要性。在本实验条件下,只有在高葡萄糖水平下才会发生 NETs 释放。五羟基查尔酮是唯一能够调节 NETs 释放的查尔酮。这项研究提供了关于查尔酮骨架的重要考虑因素及其在生理和高葡萄糖条件下对人中性粒细胞活性的调节作用,证明了它们作为补充抗糖尿病药物的潜在用途。